SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-104471
Filing Date
2010-11-12
Accepted
2010-11-12 07:09:53
Documents
4
Period of Report
2010-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c08381e8vk.htm 8-K 11594
2 EXHIBIT 99.1 c08381exv99w1.htm EX-99.1 66248
3 GRAPHIC c08381c0838100.gif GRAPHIC 3427
4 GRAPHIC c08381c0838101.gif GRAPHIC 1598
  Complete submission text file 0000950123-10-104471.txt   86734
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 101182611
SIC: 2834 Pharmaceutical Preparations